JEF Jefferies Financial
- 44.020
- +0.110+0.25%
- 44.020
- 0.0000.00%
Jefferies Financial News
PENN Entertainment - 8% Despite Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/14/2024 42.79% Truist Securities $23 → $25 Maintains Buy 06/04/2024 — JMP Securities Reiterates → Mark
Jefferies Financial Is Maintained at Outperform by Oppenheimer
Jefferies Financial Is Maintained at Outperform by Oppenheimer
Jefferies Financial Gr Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/14/2024 29.81% Oppenheimer $56 → $57 Maintains Outperform 04/30/2024 27.53% Oppenheimer $54 → $56 Maint
Oppenheimer Maintains Jefferies Financial(JEF.US) With Buy Rating, Raises Target Price to $57
Oppenheimer analyst Chris Kotowski maintains $Jefferies Financial(JEF.US)$ with a buy rating, and adjusts the target price from $56 to $57.According to TipRanks data, the analyst has a success rate of
Express News | Jefferies Financial Group Inc. : Oppenheimer Raises Target Price to $57 From $56
S&P 500 Futures Fall In Premarket Trading; Canadian Natural Rscs, Frontline Lag
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Bruker Corp. (BRKR) was up 3.0% in pre-market tradi
Gamestop's first-quarter sales revenue was $882 million, with a net loss of $36.7 million after adjustment.
On the evening of June 7, Sina Technology reported that GameStop released its Q1 2024 financial report as of May 4. The net sales were USD 882 million, down from USD 1.237 billion in the same period last year. The net loss was USD 32.3 million, down from USD 50.5 million in the same period last year. Adjusted net loss, not in accordance with US GAAP, was USD 36.7 million, down from USD 42.3 million in the same period last year. A maximum of 75 million common shares can be sold. On May 17, 2024, GameStop signed with Jefferies Financial.
BlackRock Hires Jefferies' Chan to Lead Southeast Asia Private Credit
Express News | NYSE Order Imbalance 50060.0 Shares on Sell Side
Medable to Present at Jefferies Global Healthcare Conference
PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading evidence-generation platform provider for modern clinical trials, today announced that Medable Co-founder and CEO Michelle Longmire will p
Vistagen to Present at the Jefferies Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$VTGN #mentalhealth--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies
Resolution Therapeutics to Participate in the Jefferies Global Healthcare Conference
EDINBURGH, Scotland and LONDON, May 28, 2024 /PRNewswire/ -- Resolution Therapeutics Limited ("Resolution" or "Company"), a clinical-stage biopharmaceutical company pioneering engineered autologous m
Those Who Invested in Jefferies Financial Group (NYSE:JEF) Five Years Ago Are up 240%
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can see its share price rise well over 100%. One great example is Jefferies Financia
Millennium Asked Weiss to Cut Staff, Expel Clients in Deal Talks
Overnight news: Hwang In-hoon's net worth exceeds 90 billion US dollars, Tesla's latest report does not mention sales targets, and the ECB is still expected to cut interest rates in June
For more global financial information, please follow the 7×24 hour real-time financial news market closing: US stocks closed down more than 600 points, Nvidia hit a record high, top 20 US stock turnover on May 23: Nvidia broke through $1,000 to reach a record high, US WTI crude oil closed down 0.9% for the fourth day in a row on Thursday. Most popular Chinese securities fell 4.5%, and NIO fell 8.5%. The main European stock index closed down with mixed results. Macro US 30-year mortgage interest rates fell below for the first time since early April The United Nations raised the global economy
Station B executives interpret the Q1 financial report: the number of UP owners receiving revenue through delivery increased 100% year-on-year
Nasdsaq: BILI; HKEX: 9626) released financial results for the first quarter of 2024 ending March 31: total net revenue was 5.66 billion yuan, up 12% year on year. Net loss of 764.6 million yuan compared with net loss of 629.6 million yuan for the same period last year. Without US GAAP, the adjusted net loss was 455.9 million yuan, a decrease of 56% over the previous year. After the financial report was released, Bilibili Chairman and CEO Chen Rui, Vice Chairman and Chief Operating Officer Li Ni, CFO Fan Xin and other company executives attended the subsequent earnings conference call to interpret the key points of the financial report
Unusual Options Activity: CCJ, WBD and Others Attract Market Bets
EST May 22nd Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
AstraZeneca plans to nearly double sales to $80 billion by 2030
British pharmaceutical giant AstraZeneca said on Tuesday that its goal is to reach 80 billion US dollars in sales by 2030, nearly double the 45.8 billion US dollars in 2023. The company said it plans to launch 20 new drugs by 2030 to meet new gross revenue targets. Earlier, investment bank Jefferies (Jefferies) predicted that by 2031, AstraZeneca's annual sales would exceed 70 billion US dollars. Astra set this goal ahead of its first Investor Day event in 10 years. The company's CEO Suboke (Suboco) said he wants AstraZeneca to compete fiercely
Jefferies Financial Group Inc's Dividend Analysis
Zealand Pharma Shares Attractive Ahead of Key Obesity Drug Data -- Market Talk
0901 GMT - Zealand Pharma's apparent share selloff on competitor data is an opportunity, in Jefferies's view. Zealand Pharma has a pipeline of obesity drugs and shares have risen 66% this year, but th
Analysis
Price Target
No Data
